Dr Mark Kris highlights a recent study on osimertinib in NSCLC and outlines the best approaches for treatment beyond progression.
Something happens when a rat starts running. Not just the obvious things, the faster heart, the warming muscles, the rhythmic percussion of paws against the wheel. Something quieter. Something that ...
Northwestern Medicine scientists led by Joseph Bass, MD, Ph.D., the Charles F. Kettering Professor of Endocrinology and ...
News-Medical.Net on MSN
Single receptor PAR1 controls opposing responses in blood vessels
Researchers at the University of California San Diego have uncovered how a single protein triggers two opposite responses in blood vessels - one inflammatory and one protective. This protein, a ...
Manage your stage 3 ET diagnosis with this guide on high-risk treatments, side effects and new NCCN-preferred options to empower your next visit. While essential thrombocythemia (ET) is classified as ...
BACKGROUND: Right ventricular failure drives both morbidity and mortality in pulmonary arterial hypertension (PAH), but the mechanism of transition from compensated right ventricle (cRV) to ...
According to the Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation, patients with heart failure are classified into: heart failure with reduced ejection fraction (HFrEF, LVEF ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results